Global Microarray Market to Catapult to $7.4 Billion by 2018

Global Microarray Market to Catapult to $7.4 Billion by 2018 
NEW YORK, NY -- (Marketwired) -- 08/12/13 --
cites in its newly published "Microarray Markets" report that the
global microarray market will catapult to $7.4 billion by 2018. For
more information, visit:  
Microarrays can be categorized into five main modalities: DNA,
protein, tissue, low complexity and carbohydrate. The largest
contributor to the microarrays market is the DNA microarrays segment,
which is projected to grow at a compound annual growth rate (CAGR) of
over 15%. North America is the largest regional microarray market
with 40% of the market, followed by Europe, which has 25% of the
market, and Asia, which has 18% of the market. 
The "Microarray Markets" report covers: 

--  DNA Microarrays
--  Protein Microarrays
--  Tissue Microarrays
--  Low Complexity Microarrays
--  Carbohydrate Microarrays
--  Forward Phase Microarrays
--  Reverse Phase Microarrays
--  Peptoid Arrays
--  Nucleic Acid Programmable Protein Arrays (NAPPA)
--  Antibody Microarrays
--  Tiling Arrays
--  Epigenetic Mapping Arrays
--  Cytokine Arrays
--  Whole Proteome Arrays
--  Aptamer Arrays
--  Cell-Free Arrays
--  Protein Nanoarrays
--  Lab-on-a-Chip Technologies

The "Microarray Markets" report examines companies manufacturing
microarray equipment and supplies in the world. Companies covered
include: Affymetrix, Agilent, Applied Biosystems/Invitrogen, Applied
Microarrays, Arrayit, AutoGenomics, AyoxxA, BioCat, BioChain,
BioForce, BioGenex, Biolog, Biomedical, bioMerieux, Biometrix,
Bio-Rad, Cancer Genetics, Cepheid, Clontech, CombiMatrix, CYBRDI,
DiagnoSwiss, Discerna, EMD Millipore, Eurogentec, Exiqon, Fluidigm,
Gamida for Life Group, GE Healthcare, Grace Bio-Labs, Great Basin,
Greiner Bio-One, Gyros AB, Healthcare IT, Illumina, Imgenex, Immucor,
InDevR, Isu Abxis, LC Sciences, Lineagen, Luminex, Maine
Manufacturing, Meso Scale Discovery, Microarrays, Microbionix,
Mingyuan Medicare, MiraiBio, Molecular Devices, Monogram, Myriad
Genetics, NextGen, One Lambda, OriGene, Orla Protein, Oxford Gene,
Oxford Nanopore, PamGene BV, Partek, Pepscan, Perkin Elmer, Phalanx,
PharmaSeq, Platypus, Protagen, ProteinOne, ProteoGenix, QIAGEN, R&D
Systems, Radix BioSolutions, Randox, RayBiotech, Roche NimbleGen,
Sequenom, Sigma-Aldrich, SmartBead, SomaLogic, SQI, SuperBioChips,
Theranostic Health, Toray Industries, Trans Genic, US Biomax,
Veredus, Zeptosens, Zeus Scientific and Zyagen. 
Detailed charts with sales forecasts and marketshare data are
included. For more information, visit: 
About is a global leader in the biotechnology,
healthcare and life sciences market research publishing. For more
information, please visit  
Important Notice 
The statements contained in this news release that are
forward-looking are based on current expectations that are subject to
a number of uncertainties and risks, and actual results may differ
Media Relations
Press spacebar to pause and continue. Press esc to stop.